Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05318573 |
|---|---|
| Brief Title: | A Study to Evaluate Safety, Efficacy of FF-10832 in Combination With Pembrolizumab in Solid Tumors |
| First Submitted : | March 29, 2022 |
| First Submitted that Met QC Criteria : | April 7, 2022 |
| First Posted : | April 8, 2022 |
| Last Update Submitted that Met QC Criteria : | October 19, 2022 |
| Last Update Posted : | October 20, 2022 |